พบ "Public health policy"ทั้งหมด 1,253 ผลลัพธ์
เรียงลำดับตาม
เรียงลำดับตาม
ความเกี่ยวข้อง
จุลสารปีที่ 11 ฉบับที่ 32 มกราคม-เมษายน 2561: เปิดใจให้ HTA เปิดรับความคุ้มค่าด้านสาธารณสุข
เรื่องราวของคนทำ HTA ซึ่งก็คือนักวิจัยในอีกแนวหนึ่ง ซึ่งผ่านการศึกษาด้าน HTA มาโดยเฉพาะ ในประเทศไทยมีหลายหน่วยงานที่สอนเรื่อง HTA และมีหลายหน่วยงานที่ทำวิจัยด้าน HTA โครงการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ (Health Intervention and TechnologyAssessment Program – HITAP) หรือไฮแทป ก็เป็น หนึ่ง
A Cost-Utility Analysis Comparing Standard Axillary Lymph Node Dissection with Sentinel Lymph Node Biopsy in Patients with Early Stage Breast Cancer in Thailand (2014)
Abstract
Objectives
In Thailand, axillary lymph node dissection (ALND) is the dominant form of treatment for breast cancer, even though the treatment often leaves patients with some degree of arm morbidity. Sentinel lymph node biopsy (SNB) is widely accepted globally as a preferable alternative pr
Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in Thailand. (2014)
Background: In Thailand, there has been no economic evaluation study of adjuvant chemotherapy for stage III colon cancer patients after resection. Objective: This study aims to evaluate the cost-utility of all chemotherapy regimens currently used in Thailand compared with the adjuvant 5-fluorouracil
Cost-utility analysis of great saphenous vein ablation with radiofrequency, foam and surgery in the emerging health-care setting of Thailand (2015)
Boonying Siribumrungwong1, Pinit Noorit2,
Chumpon Wilasrusmee3, Pattara Leelahavarong4,
Ammarin Thakkinstian5 and Yot Teerawattananon4
Abstract
Objectives: To conduct economic evaluations of radiofrequency ablation, ultrasound-guided foam sclerotherapy and surgery for great saphenous vein ab
Cost utility and budget impact analysis of drug treatments in pulmonary arterial hypertension associated with congenital heart diseases in Thailand
Objective: This study aims to compare the lifetime costs and health outcomes of both first-line and sequential combination treatments with standard treatment for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD) (PAH-CHD) patients. Methods: A cost-utility analysis
Economic Evaluation of Sildenafil for the Treatment of Pulmonary Arterial Hypertension in Indonesia
Abstract
Background
This study aims to assess the cost-effectiveness and budget impact of adopting sildenafil to the benefits package for the indication of pulmonary arterial hypertension (PAH), compared to beraprost.
Methods
Based on a societal perspective, a model-based economic evaluation
Growth and capacity for cost-effectiveness analysis in Africa
Abstract
As economic evaluation becomes increasingly essential to support universal health coverage (UHC), we aim to understand the growth, characteristics, and quality of cost-effectiveness analyses (CEA) conducted for Africa and to assess institutional capacity and relationship patterns among a
‘It takes two to tango’: Bridging the gap between country need and vaccine product innovation
Abstract
Background
Despite a growing global commitment to universal health coverage, considerable vaccine coverage and uptake gaps persist in resource-constrained settings. One way of addressing the gaps is by ensuring product innovation is relevant and responsive to the needs of these contexts
What Can We Learn From Others to Develop a Regional Centre for Infectious Diseases in ASEAN?; Comment on “Operationalising Regional Cooperation for Infectious Disease Control: A Scoping Review of Regional Disease Control Bodies and Networks”
The coronavirus disease 2019 (COVID-19) pandemic has brought the need for regional collaboration on disease prevention and control to the fore. The review by Durrance-Bagale et al offers insights on the enablers, barriers and lessons learned from the experience of various regional initiatives. Trans
Pattern of OPD utilisation during the COVID-19 pandemic under the Universal Coverage Scheme in Thailand: what can 850 million records tell us?
Out-patient department (OPD) is a crucial component of the healthcare systems in low- and middle-income countries including Thailand. A considerable impact of coronavirus disease 2019 (COVID-19) pandemic and its control measures, especially the lockdown, on utilisation of OPD services was expected.
10 / หน้า